The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dairy Crest Group PLC

25 Feb 2019 15:00

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Sand Grove Capital Management LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Sand Grove Opportunities Master Fund Ltd

Sand Grove Tactical Fund LP

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dairy Crest Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22 February 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 25p ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: 4,550,000 2.92%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

4,550,000 2.92%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
25p ordinary CFD Opening a long position 2,200,000 624.20
25p ordinary CFD Increasing long position 2,100,000 623.71
25p ordinary CFD Increasing long position 250,000 625.00

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 25 February 2019
Contact name: Joe Smith
Telephone number: +44 203 770 8623

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190225005542/en/

Copyright Business Wire 2019

Date   Source Headline
18th Nov 201610:02 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Nov 20167:00 amRNSInterim Results
31st Oct 201612:23 pmRNSTotal Voting Rights & Capital
30th Sep 201610:17 amRNSTotal Voting Rights
19th Sep 20167:00 amRNSTrading Statement
31st Aug 20169:53 amRNSTotal Voting Rights & Capital
12th Aug 20165:22 pmRNSDirector/PDMR Shareholding
1st Aug 201611:40 amRNSTotal Voting Rights
21st Jul 20164:01 pmRNSDirector/PDMR Shareholding
21st Jul 20164:00 pmRNSDirector/PDMR Shareholding
20th Jul 20162:45 pmRNSDirector/PDMR Shareholding
20th Jul 20169:23 amRNSResults of AGM held on 19 July 2016
19th Jul 20164:59 pmRNSBoard Appointment
19th Jul 20163:59 pmRNSNon-executive Director Notification
19th Jul 20167:00 amRNSAGM and Interim Management Statement
8th Jul 20163:07 pmRNSDirector/PDMR Shareholding
30th Jun 201611:05 amRNSTotal Voting Rights
24th Jun 20162:58 pmRNSDirector/PDMR Shareholding
20th Jun 20167:00 amRNS2016 Annual Report and Accounts and Notice of AGM
3rd Jun 20163:11 pmRNSDirector/PDMR Shareholding
2nd Jun 201612:10 pmRNSBlock listing Interim Review
31st May 20169:51 amRNSTotal Voting Rights
19th May 20167:00 amRNSPreliminary Results
3rd May 201611:10 amRNSTotal Voting Rights & Capital
1st Apr 201612:08 pmRNSTotal Voting Rights
1st Mar 20164:12 pmRNSDirector/PDMR Shareholding
1st Mar 20162:44 pmRNSTotal Voting Rights & Capital
26th Feb 20162:12 pmRNSBlocklisting Interim Review
11th Feb 20167:00 amRNSInterim Management Statement
1st Feb 20165:01 pmRNSDirector/PDMR Shareholding
29th Jan 201610:51 amRNSTotal Voting Rights
8th Jan 20163:54 pmRNSDirector/PDMR Shareholding
6th Jan 20169:47 amRNSTotal Voting Rights
29th Dec 20157:00 amRNSCompletion of sale of Dairies operations
21st Dec 20157:00 amRNSOwnership of Galacto-Oligosaccharide business
1st Dec 201510:58 amRNSTotal Voting Rights
17th Nov 201511:25 amRNSBlocklisting Interim Review
16th Nov 20153:28 pmRNSDirector/PDMR Shareholding
13th Nov 201512:06 pmRNSAdditional Listing
5th Nov 20157:00 amRNSInterim Results
30th Oct 201512:15 pmRNSTotal Voting Rights
29th Oct 20153:08 pmRNSHolding(s) in Company
22nd Oct 20153:37 pmRNSHolding(s) in Company
19th Oct 20153:17 pmRNSSale of Dairies will complete in December 2015
19th Oct 20159:30 amRNSHolding(s) in Company
15th Oct 201510:42 amRNSHolding(s) in Company
30th Sep 20152:52 pmRNSSale of Dairy Crest's Dairies operations
30th Sep 201510:42 amRNSTotal Voting Rights
22nd Sep 20157:00 amRNSTrading Statement
1st Sep 20159:40 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.